Abstract
The risk-benefit balance when aspirin is compared with aspirin combined with ticlopidine is being investigated in several multicentre trials (MUSIC and WEST II versus TASTE, MUST, and STARS respectively). Cardiologists follow one of two strategies. Some prefer a more aggressive antiplatelet regimen, disregarding the risk of neutropenia (0.7%) because they want to avoid lessening the therapeutic effect of vessel patency obtained with stent implantation. Others give only aspirin (a money saving approach) confident that IVUS inspection (an expensive approach) will allow an adequate evaluation of full stent expansion and lesion coverage, despite a more pronounced activation of the coagulation cascade. Our impression so far is that the combination of ticlopidine and aspirin has a more favourable risk-effect balance.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Colombo A., Hall P., Nakamura S., Almagor Y., Maiello L., Martini G., Gaglione A., Goldberg S. L., Tobis J. M. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995 Mar 15;91(6):1676–1688. doi: 10.1161/01.cir.91.6.1676. [DOI] [PubMed] [Google Scholar]
- Golino P., Piscione F., Benedict C. R., Anderson H. V., Cappelli-Bigazzi M., Indolfi C., Condorelli M., Chiariello M., Willerson J. T. Local effect of serotonin released during coronary angioplasty. N Engl J Med. 1994 Feb 24;330(8):523–528. doi: 10.1056/NEJM199402243300802. [DOI] [PubMed] [Google Scholar]
- McGarry T. F., Jr, Gottlieb R. S., Morganroth J., Zelenkofske S. L., Kasparian H., Duca P. R., Lester R. M., Kreulen T. H. The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty. Am Heart J. 1992 Jun;123(6):1445–1451. doi: 10.1016/0002-8703(92)90793-u. [DOI] [PubMed] [Google Scholar]
- McTavish D., Faulds D., Goa K. L. Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs. 1990 Aug;40(2):238–259. doi: 10.2165/00003495-199040020-00006. [DOI] [PubMed] [Google Scholar]
- Neumann F. J., Gawaz M., Ott I., May A., Mössmer G., Schömig A. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting. J Am Coll Cardiol. 1996 Jan;27(1):15–21. doi: 10.1016/0735-1097(95)00433-5. [DOI] [PubMed] [Google Scholar]
- Patrono C. Aspirin as an antiplatelet drug. N Engl J Med. 1994 May 5;330(18):1287–1294. doi: 10.1056/NEJM199405053301808. [DOI] [PubMed] [Google Scholar]
- Schömig A., Neumann F. J., Kastrati A., Schühlen H., Blasini R., Hadamitzky M., Walter H., Zitzmann-Roth E. M., Richardt G., Alt E. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996 Apr 25;334(17):1084–1089. doi: 10.1056/NEJM199604253341702. [DOI] [PubMed] [Google Scholar]
- Serruys P. W., Di Mario C. Who was thrombogenic: the stent or the doctor? Circulation. 1995 Mar 15;91(6):1891–1893. doi: 10.1161/01.cir.91.6.1891. [DOI] [PubMed] [Google Scholar]
- Serruys P. W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., Emanuelsson H., Marco J., Legrand V., Materne P. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994 Aug 25;331(8):489–495. doi: 10.1056/NEJM199408253310801. [DOI] [PubMed] [Google Scholar]
- de Feyter P. J., van den Brand M., Laarman G. J., van Domburg R., Serruys P. W., Suryapranata H., Jaarman G. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up. Circulation. 1991 Mar;83(3):927–936. doi: 10.1161/01.cir.83.3.927. [DOI] [PubMed] [Google Scholar]